FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

7/19/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   7/19/2017     P    7000   A $0.0219   21778019   D    
Common Stock   7/19/2017     P    2000   A $0.0219   21780019   D    
Common Stock   7/19/2017     P    2000   A $0.0219   21782019   D    
Common Stock   7/19/2017     P    2000   A $0.0217   21784019   D    
Common Stock   7/19/2017     P    2000   A $0.0218   21786019   D    
Common Stock   7/19/2017     P    5000   A $0.0218   21791019   D    
Common Stock   7/19/2017     P    10000   A $0.0215   21801019   D    
Common Stock   7/19/2017     P    5000   A $0.0215   21806019   D    
Common Stock   7/19/2017     P    2000   A $0.0215   21808019   D    
Common Stock   7/19/2017     P    5000   A $0.0207   21813019   D    
Common Stock   7/19/2017     P    5000   A $0.0206   21818019   D    
Common Stock   7/19/2017     P    2000   A $0.0214   21820019   D    
Common Stock   7/19/2017     P    5000   A $0.0206   21825019   D    
Common Stock   7/19/2017     P    2000   A $0.0206   21827019   D    
Common Stock   7/19/2017     P    2000   A $0.0215   21829019   D    
Common Stock   7/19/2017     P    5000   A $0.0215   21834019   D    
Common Stock   7/19/2017     P    2000   A $0.0218   21836019   D    
Common Stock   7/19/2017     P    2000   A $0.022   21838019   D    
Common Stock   7/19/2017     P    5000   A $0.0219   21843019   D    
Common Stock   7/19/2017     P    2000   A $0.021   21845019   D    
Common Stock   7/19/2017     P    2000   A $0.021   21847019   D    
Common Stock   7/19/2017     P    5000   A $0.021   21852019   D    
Common Stock   7/19/2017     P    2000   A $0.021   21854019   D    
Common Stock   7/19/2017     P    2000   A $0.0209   21856019   D    
Common Stock   7/19/2017     P    2000   A $0.021   21858019   D    
Common Stock   7/19/2017     P    5370   A $0.021   21863389   D    
Common Stock   7/19/2017     P    2000   A $0.021   21865389   D    
Common Stock   7/19/2017     P    5000   A $0.021   21870389   D    
Common Stock   7/19/2017     P    2000   A $0.0219   21872389   D    
Common Stock   7/20/2017     P    2000   A $0.0216   21874389   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 7/24/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.